The process involves drawing a blood sample from the pregnant woman, usually after the 10th week of pregnancy. The sample is then analyzed to isolate and examine the fetal DNA. Advanced techniques like next-generation sequencing are used to detect potential chromosomal abnormalities, such as Down syndrome, Trisomy 18, and Trisomy 13.
